Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

259.82
BATS BZX Real-Time Price
As of 2:57pm ET
 +2.61 / +1.01%
Today’s Change
106.00
Today|||52-Week Range
260.79
+81.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
AssetsCash808.8M322.6M12.2B958.0M
 
 
 
 
 
Short Term Investment Cash278.5M-479.1M1.5B-903.5M
 
 
 
 
 
Cash & Short Term Investments841.9M322.6M12.2B958.0M
 
 
 
 
 
 
ReceivablesReceivables1.9B2.1B2.1B2.4B
 
 
 
 
 
 
InventoriesInventories932.7M950.6M998.9M1.2B
 
 
 
 
 
 
Current AssetsOther Current Assets758.9M844.1M865.2M1.8B
 
 
 
 
 
Current Assets4.4B4.2B16.2B6.3B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.3B2.3B1.3B1.4B
 
 
 
 
 
Depreciation---977.9M----
 
 
Intangible Assets21.1B20.6B20.7B40.4B
 
 
 
 
 
Other Assets21.3B20.8B20.9B40.5B
 
 
 
 
 
Total Assets27.1B26.4B38.6B48.3B
 
 
 
 
 
 
LiabilitiesAccounts Payable323.3M398.0M352.5M415.8M
 
 
 
 
 
Short Term Debt690.6M7.1M122.8M590.9M
 
 
 
 
 
Accrued Expenses2.0B258.7M2.4B3.1B
 
 
 
 
 
Other Current Liabilities2.1B2.0B2.6B3.2B
 
 
 
 
 
Other Liabilities3.1B2.7B3.1B4.3B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt15.6B15.3B25.9B30.3B
 
 
 
 
 
Deferred Taxes-2.4B-2.2B-2.1B-6.1B
 
 
 
 
 
Other Liabilities419.9M466.7M407.8M723.2M
 
 
 
 
 
Total Liabilities21.8B20.9B32.0B41.8B
 
 
 
 
 
 
EquityMinority Interest-1.0M-800.0K-800.0K-1.4M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity5.1B5.3B6.5B6.4B
 
 
 
 
 
Total Shareholder Equity5.1B5.3B6.5B6.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding334.0M334.4M342.3M342.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.